7-24800272-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015550.4(OSBPL3):c.2575G>A(p.Asp859Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,604,726 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015550.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSBPL3 | NM_015550.4 | c.2575G>A | p.Asp859Asn | missense_variant | 23/23 | ENST00000313367.7 | NP_056365.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSBPL3 | ENST00000313367.7 | c.2575G>A | p.Asp859Asn | missense_variant | 23/23 | 1 | NM_015550.4 | ENSP00000315410.2 |
Frequencies
GnomAD3 genomes AF: 0.00158 AC: 241AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00124 AC: 311AN: 250694Hom.: 0 AF XY: 0.00140 AC XY: 190AN XY: 135534
GnomAD4 exome AF: 0.00256 AC: 3723AN: 1452518Hom.: 16 Cov.: 27 AF XY: 0.00251 AC XY: 1818AN XY: 723180
GnomAD4 genome AF: 0.00158 AC: 241AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.00132 AC XY: 98AN XY: 74406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | The c.2575G>A (p.D859N) alteration is located in exon 23 (coding exon 22) of the OSBPL3 gene. This alteration results from a G to A substitution at nucleotide position 2575, causing the aspartic acid (D) at amino acid position 859 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at